Cargando…
Ultrasonographic assessment reveals detailed distribution of synovial inflammation in Blau syndrome
INTRODUCTION: Arthritis is the most frequent manifestation of Blau syndrome, an autoinflammatory disorder caused by the genetic mutation of NOD2. However, detailed information on arthritis in Blau syndrome on which the therapeutic strategy should be based on is lacking. This multi-center study aimed...
Autores principales: | Ikeda, Kei, Kambe, Naotomo, Takei, Syuji, Nakano, Taiji, Inoue, Yuzaburo, Tomiita, Minako, Oyake, Natsuko, Satoh, Takashi, Yamatou, Tsuyoshi, Kubota, Tomohiro, Okafuji, Ikuo, Kanazawa, Nobuo, Nishikomori, Ryuta, Shimojo, Naoki, Matsue, Hiroyuki, Nakajima, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060485/ https://www.ncbi.nlm.nih.gov/pubmed/24713464 http://dx.doi.org/10.1186/ar4533 |
Ejemplares similares
-
NOD2 Mutation-Associated Case with Blau Syndrome Triggered by BCG Vaccination
por: Arakawa, Akiko, et al.
Publicado: (2021) -
Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis
por: Matsuda, Tomoko, et al.
Publicado: (2022) -
Sustained Surface ICAM-1 Expression and Transient PDGF-B Production by Phorbol Myristate Acetate-Activated THP-1 Cells Harboring Blau Syndrome-Associated NOD2 Mutations
por: Nishiyama, Mizuho, et al.
Publicado: (2021) -
Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome
por: Ueki, Yoko, et al.
Publicado: (2023) -
Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria
por: Nakamura, Yuumi, et al.
Publicado: (2009)